Home » ytterbium-176

SHINE breaks ground on HQ and Therapeutics production facility

SHINE Medical Technologies LLC today announced that the company has broken ground on a new 54,000-square-foot facility that will house its corporate headquarters and a large-scale production facility for the Therapeutics division it established last year.

2022-09-08T09:13:45-05:00December 16, 2020|Safer, Healthier, Cleaner, News, News Releases, Therapeutics, 2020|

SHINE Licenses Lu-177 Separation Process

SHINE Medical Technologies and Institute of Organic Chemistry and Biochemistry of the CAS have entered into an intellectual property license agreement providing SHINE with a global, exclusive license to a novel method for separating rare earth elements.  SHINE will use the innovation to produce lutetium-177 (Lu-177) for the treatment of cancer.

2021-12-17T17:45:41-06:00May 15, 2019|News Releases, Archived, Medical Isotopes, 2019|
Go to Top